OHA updates COVID-19 vaccination data for rarest race and ethnicity
Starting Tuesday, OHA’s COVID-19 Vaccination Metrics dashboard will include more precise population estimates for race and ethnicity data at the state and county level.
News & Stories for Oregonians
Starting Tuesday, OHA’s COVID-19 Vaccination Metrics dashboard will include more precise population estimates for race and ethnicity data at the state and county level.
The “Pow! Kick! Bang!” of the comic Fighting Covid hasn’t lost its punch. Nine months after NW Disability Support (NWDS) debuted the comic book and its follow-up, Beating COVID,the non-profit has delivered the graphic tales to more than 250,000 households.
The Western States Scientific Safety Review Workgroup has confirmed its support of the recommendation that people 18 and older receive an mRNA (Pfizer or Moderna) COVID-19 vaccine over Johnson & Johnson’s COVID-19 vaccine, given the greater effectiveness and stronger safety profile of mRNA vaccines.
Today, Governor Brown, Oregon Health Authority (OHA) and Oregon Health & Science University (OHSU) leadership shared information about the latest projection about the spread of COVID-19 in Oregon due to the new Omicron variant.
For many folks, it wouldn’t be the holidays without college students coming home for winter break. Given the ongoing risk of spreading COVID-19, as well as the new Omicron variant, here are several ways college students can keep their hometown households safe during the academic break.
While seated in the observation area following her COVID-19 booster dose, Carolyn Smith of Park Rose used the time wisely by posting information on social media about the experience. She was, in fact, inside a former Kmart building in Gresham that had been transformed into a winter wonderland vaccination clinic located at 440 NW Burnside Rd.
If you plan to travel by air, bus, or train this holiday season, consider these tips.
The Food and Drug Administration (FDA), the Centers for Disease Control and Prevention (CDC) and the Western States Scientific Safety Review Committee today authorized for emergency use the Pfizer-BioNTech COVID-19 vaccine for 16- and 17-year-olds, at least six months after they received their second shot of that vaccine.
On Dec. 8, 2021, the Food and Drug Administration (FDA) authorized AstraZeneca’s Evusheld under emergency use for prevention of COVID-19 infection in certain adults and children. Evusheld is a long-acting monoclonal antibody therapy.
A breakthrough case is when a vaccinated person gets infected with the virus they were vaccinated against. When more people get vaccinated, there are more people in the pool who can get a breakthrough infection. As vaccination rates go up, breakthrough infections may also go up.